TY - JOUR
T1 - Complications 18 years after polyacrylamide hydrogel augmentation mammoplasty
T2 - A case report and histopathological analysis
AU - DeLuca, Matthew
AU - Shapiro, Alexandra
AU - Banayan, Elliot
AU - Zielinski, Gregory
AU - Karanetz, Irena
AU - Asarian, Armand
AU - Xiao, Philip
N1 - Publisher Copyright:
© 2021 Published by Oxford University Press and JSCR Publishing Ltd.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Polyacrylamide hydrogel (PAAG) is a synthetic substance previously used as an injectable material for augmentation mammoplasty. Current literature has demonstrated that the average time from PAAG injection to the onset of complication ranges from 6 to 39 months. We present a unique case report describing the onset of complications 18 years after PAAG augmentation mammoplasty. To the best of our knowledge, the presentation of a healthy female who experienced unprovoked expansion of breast tissue >15 years after polyacrylamide injection has not been previously reported in surgical literature. This suggests that serious complications of PAAG injection may occur later than the literature has previously described. Importantly, this case is the first demonstration of the successful surgical removal of polyacrylamide 18 years after injection. Additionally, this case also provides a histopathological analysis of breast capsules which showed evidence of an extensive chronic inflammatory reaction to polyacrylamide, consistent with previous reports.
AB - Polyacrylamide hydrogel (PAAG) is a synthetic substance previously used as an injectable material for augmentation mammoplasty. Current literature has demonstrated that the average time from PAAG injection to the onset of complication ranges from 6 to 39 months. We present a unique case report describing the onset of complications 18 years after PAAG augmentation mammoplasty. To the best of our knowledge, the presentation of a healthy female who experienced unprovoked expansion of breast tissue >15 years after polyacrylamide injection has not been previously reported in surgical literature. This suggests that serious complications of PAAG injection may occur later than the literature has previously described. Importantly, this case is the first demonstration of the successful surgical removal of polyacrylamide 18 years after injection. Additionally, this case also provides a histopathological analysis of breast capsules which showed evidence of an extensive chronic inflammatory reaction to polyacrylamide, consistent with previous reports.
UR - http://www.scopus.com/inward/record.url?scp=85126784624&partnerID=8YFLogxK
U2 - 10.1093/jscr/rjab276
DO - 10.1093/jscr/rjab276
M3 - Article
AN - SCOPUS:85126784624
SN - 2042-8812
VL - 2021
JO - Journal of Surgical Case Reports
JF - Journal of Surgical Case Reports
IS - 6
M1 - rjab276
ER -